|
1
|
Ferrero-Miliani L, Nielsen OH, Andersen PS
and Girardin SE: Chronic inflammation: importance of NOD2 and NALP3
in interleukin-1beta generation. Clin Exp Immunol. 147:227–235.
2007.PubMed/NCBI
|
|
2
|
Rosenwasser LJ: Current understanding of
the pathophysiology of allergic rhinitis. Immunol Allergy Clin
North Am. 31:433–439. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rose S, Weld-Moore R, Ghazali N and Newman
L: ‘I’ve got hay-fever and my mouth is stinging!’. Br Dent J.
211:369–370. 2011.
|
|
4
|
Olivera A and Rivera J: An emerging role
for the lipid mediator sphingosine-1-phosphate in mast cell
effector function and allergic disease. Adv Exp Med Biol.
716:123–142. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kuna P, Reddigari SR, Rucinski D,
Oppenheim JJ and Kaplan AP: Monocyte chemotactic and activating
factor is a potent histamine-releasing factor for human basophils.
J Exp Med. 175:489–493. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang SL, Malany S, Wang Q, Santos MA,
Crowe PD and Maki RA: Histamine induces interleukin-6 expression in
the human synovial sarcoma cell line (SW982) through the H1
receptor. Inflamm Res. 55:393–398. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Thomas PS: Tumor necrosis factor-alpha:
the role of this multifunctional cytokine in asthma. Immunol Cell
Biol. 79:132–140. 2001. View Article : Google Scholar
|
|
8
|
Nakae S, Suto H, Kakurai M, Sedgwick JD,
Tsai M and Galli SJ: Mast cells enhance T cell activation:
Importance of mast cell-derived TNF. Proc Natl Acad Sci USA.
102:6467–6472. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bodreau RT, Hoskin DW and Lin TJ:
Phosphatase inhibition potentiates IL-6 production by mast cells in
response to FcepsilonRI-mediated activation: involvement of p38
MAPK. J Leukoc Biol. 76:1075–1081. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Murayama T, Mukaida N, Sadanari H,
Yamaguchi N, Khabar KS, Tanaka J, Matsushima K, Mori S and Eizuru
Y: The immediate early gene 1 product of human cytomegalovirus is
sufficient for up-regulation of interleukin-8 gene expression.
Biochem Biophys Res Commun. 279:298–304. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kuprsh DV, Udalova IA, Turetskaya RL, Rice
NR and Nedospasov SA: Conserved kappa B element located downstream
of the tumor necrosis factor alpha gene: distinct NF-kappa B
binding pattern and enhancer activity in LPS activated murine
macrophages. Oncogene. 11:97–106. 1995.
|
|
12
|
Galien R, Evans HF and Garcia T:
Involvement of CCAAT/enhancer-binding protein and nuclear
factor-kappa B binding site in interleukin-6 promoter inhibition by
estrogens. Mol Endocrinol. 10:713–722. 1996.PubMed/NCBI
|
|
13
|
Chang JS, Chiang LC, Chen CC, Liu LT, Wang
KC and Lin CC: Antileukemic activity of Bidens pilosa L.
var. minor(Blume) Sherff and Houttuynia cordata
Thunb. Am J Chin Med. 29:303–312. 2001.
|
|
14
|
Chiang LC, Chang JS, Chen CC, Ng LT and
Lin CC: Anti-herpes simplex virus activity of Bidens pilosa
and Houttuynia cordata. Am J Chin Med. 31:355–362. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li GZ, Chai OH, Lee MS, Han EH, Kim HT and
Song CH: Inhibitory effects of Houttuynia cordata water
extracts on anaphylactic reaction and mast cell activation. Biol
Pharm Bull. 28:1864–1868. 2005.
|
|
16
|
Lu HM, Liang YZ, Yi LZ and Wu XJ:
Anti-inflammatory effect of Houttuynia cordata injection. J
Ethnopharmacol. 104:245–249. 2006. View Article : Google Scholar
|
|
17
|
Chen YY, Liu JF, Chen CM, Chao PY and
Chang TJ: A study of the antioxidative and antimutagenic effects of
Houttuynia cordata Thunb. using an oxidized frying oil-fed
model. J Nutr Sci Vitaminol (Tokyo). 49:327–333. 2003.PubMed/NCBI
|
|
18
|
Kim IS, Kim JH, Kim JS, Yun CY, Kim DH and
Lee JS: The inhibitory effect of Houttuynia cordata extract
on stem cell factor-induced HMC-1 cell migration. J Ethnopharmacol.
112:90–95. 2007.
|
|
19
|
Lee JS, Kim IS, Kim JH, Kim JS, Kim DH and
Yun CY: Suppressive effects of Houttuynia cordata Thunb
(Saururaceae) extract on Th2 immune response. J Ethnopharmacol.
117:34–40. 2008.
|
|
20
|
Tang YJ, Yang JS, Lin CF, Shyu WC, Tsuzuki
M, Lu CC, Chen YF and Lai KC: Houttuynia cordata Thunb
extract induces apoptosis through mitochondrial-dependent pathway
in HT-29 human colon adenocarcinoma cells. Oncol Rep. 22:1051–1056.
2009.
|
|
21
|
Bischoff SC: Role of mast cells in
allergic and non-allergic immune responses: comparison of human and
murine data. Nat Rev Immunol. 7:93–104. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mekori YA and Metcalfe DD: Mast cells in
innate immunity. Immunol Rev. 173:131–140. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Prussin C and Metcalfe DD: 4. IgE, mast
cells, basophils and eosinophils. J Allergy Clin Immunol. 111(2
Suppl): S486–S494. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kim SJ, Lee EJ, Song YS, Jeong HJ, Lee KM,
Kim HR, Chae HJ, Shin TY, Kim YK, Hong SH and Kim HM:
Cheongyeolsaseuptang inhibits production of TNF-alpha, IL-6 and
IL-8 as well as NF-kappa B activation in human mast cells. J
Ethnopharmacol. 97:83–88. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cha JY, Jung JY, Jung JY, Lee JR, Cho IJ,
Ku SK, Byun SH, Ahn YT, Lee CW, Kim SC and An WG: Inhibitory
effects of traditional herbal formula pyungwi-san on inflammatory
response in vitro and in vivo. Evid Based Complement Alternat Med.
2013:6301982013.PubMed/NCBI
|
|
26
|
Kim SR, Choi HS, Seo HS, Choi YK, Shin YC
and Ko SG: Topical application of herbal mixture extract inhibits
ovalbumin- or 2,4-dinitrochlorobenzene-induced atopic dermatitis.
Evid Based Complement Alternat Med. 2012:5454972012.PubMed/NCBI
|
|
27
|
Park E, Kum S, Wang C, Park SY, Kim BS and
Schuller-Levis G: Anti-inflammatory activity of herbal medicines:
inhibition of nitric oxide production and tumor necrosis
factor-alpha secretion in an activated macrophage-like cell line.
Am J Chin Med. 33:415–424. 2005. View Article : Google Scholar
|
|
28
|
Harada M, Nagata M and Takeuchi M:
Production of passive cutaneous anaphylaxis (PCA) and reversed PCA
by rat IgE antibody in the mouse. Experientia. 44:459–462. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Valenta R: The future of antigen-specific
immunotherapy of allergy. Nat Rev Immunol. 2:446–453.
2002.PubMed/NCBI
|
|
30
|
Galli SJ, Tsai M and Piliponsky AM: The
development of allergic inflammation. Nature. 454:445–454. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lippert U, Möller A, Welker P, Artuc M and
Henz BM: Inhibition of cytokine secretion from human leukemic mast
cells and basophils by H1- and H2-receptor antagonists. Exp
Dermatol. 9:118–124. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cruse G, Kaur D, Yang W, Duffy SM,
Brightling CE and Bradding P: Activation of human lung mast cells
by monomeric immunoglobulin E. Eur Respir J. 25:858–863. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Choi IW, Kim YS, Kim DK, Choi JH, Seo KH,
Im SY, Kwon KS, Lee MS, Ha TY and Lee HK: Platelet-activating
factor-mediated NF-kappaB dependency of a late anaphylactic
reaction. J Exp Med. 198:145–151. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mohamed MR and McFadden G: NFkB
inhibitors: strategies from poxviruses. Cell Cycle. 8:3125–3132.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Medzhitov R: Toll-like receptors and
innate immunity. Nat Rev Immunol. 1:135–145. 2001. View Article : Google Scholar : PubMed/NCBI
|
